tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

Compare NewAmsterdam Pharma Company (NAMS) vs. Competitors

249 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$34.44
$4.17B
-19.69
109.74%
11 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$35.52
$4.05B
-6.36
44.57%
12 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$59.35
$5.59B
-10.27
77.48%
19 Buy
0 Hold
0 Sell
Strong Buy
Soleno Therapeutics
$52.62
$2.72B
117.86
-24.83%
3 Buy
10 Hold
0 Sell
Hold
Kiniksa Pharmaceuticals
$47.30
$3.62B
51.87
126.78%
6 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$25.12
$5.11B
-10.43
72.07%
10 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
34.44
18.38
114.45%
VKTX
Viking Therapeutics
35.52
12.41
53.70%
XENE
Xenon
59.35
26.32
79.69%
SLNO
Soleno Therapeutics
52.62
-17.63
-25.10%
KNSA
Kiniksa Pharmaceuticals
46.92
25.70
121.11%
IMVT
Immunovant
26.55
11.09
71.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts